ReleaseWire Connect

The Hepatitis B Foundation, a world-class nonprofit research organization headquartered in Doylestown, Pa., announces the promotion of Patti McAloon to Accounting Manager.

James Horan has been named the Chief Operating and Financial Officer of the Hepatitis B Foundation, a world-class nonprofit research organization headquartered in Doylestown, Pa. Horan also serves as COO for the Foundation’s affiliate organizations, the Pennsylvania Biotechnology Center and the Institute for Hepatitis and Virus Research.

Stimulating discussion about alternative biofuels…Showcasing exciting new initiatives

Scientists working at the Hepatitis B Foundation, in partnership with Drexel University College of Medicine, think they may have discovered a reliable alternative to liver biopsy for the early detection of liver fibrosis and cirrhosis, which afflict more than 5 million Americans. People with hepatitis B and C infections, as well as fatty liver diseases, are at greatest risk for progressing to cirrhosis that can lead to liver cancer.

The Hepatitis B Foundation and the PA Biotechnology Center, in the spirit of giving, collected 1,067 pounds of non-perishable food items for a local Doylestown food pantry. The 20 day holiday food drive ended December 15 and was organized as a team competition among the 80 plus researchers and professional staff.

Peggy Farley presented several types of viral hepatitis commonly referred to as A, B and C to attendees of the free seminar at Doylestown Hospital's Health and Wellness Center. She explained the definition of the word “hepatitis” which translates to the inflammation of the liver and provided the participants with an overview of how research, conducted at the Hepatitis B Foundation’s headquarters in Bucks County, is making progress toward treatment of the disease.

The 7th Annual Regional Biotech Conference – “Biotech Success Stories: What Big And Small Companies Are Looking For” - Friday, November 9, 2007 8:30 am – 1:00 pm

Groft’s primary responsibilities as Director of Development are to provide dynamic leadership for the Foundation’s fundraising programs and build the Foundation’s base of philanthropic support. She is responsible for all fundraising activities, including annual fund, corporate and Foundation grants, special events and individual major gifts.

Bucks County’s Institute for Hepatitis and Virus Research (IHVR) and BioLeap have entered into a collaboration to develop new therapeutic compounds for the treatment of Hepatitis C. Up to 50% of patients treated with current standard therapies do not respond adequately and often suffer serious side effects from the drugs. Thus there is a critical need for new tools to treat this disease. By combining BioLeap’s leading edge computational fragment-based design capabilities with the IHVR’s extensive experience and in-depth knowledge of viral diseases, the collaboration will result in new classes of lead drug molecules with novel modes-of-action.

Earlier this month the Honorable Patrick J. Murphy of Pennsylvania in the House of Representatives stood on the floor of Congress in Washington, D.C. and recognized the accomplishments of the Hepatitis B Foundation located in Bucks County, PA. In his public statement, Congressman Murphy emphasized the importance of the Foundation’s mission.